GINOBOLT-MP1
March 28, 2026
GINOBOLT-M1 FORTE
March 28, 2026
GINOBOLT-MP2
₹950.00
Composition:
Glimepiride 2, Metformin 500, Pioglitazone 15
Packaging Detail:
10 x 10
Description
A triple combination tablet with a higher dose of Glimepiride (2 mg) combined with Metformin and Pioglitazone. It is designed for patients requiring more intensive sulfonylurea therapy alongside other insulin sensitizers.
Indications
Indications
-
Type 2 diabetes mellitus requiring stronger sulfonylurea component in triple therapy.
Side Effects
Side Effects
-
Hypoglycemia (low blood sugar) – increased risk with higher Glimepiride dose.
-
Fluid retention and edema.
-
Weight gain.
-
Nausea and gastrointestinal disturbance.
-
Increased risk of bone fractures (in women).
Reviews 0
Related products
-
BECOFLAM
₹1,850.00 -
CEFLIDE-CV
₹3,200.00 -
CEFIMOX-100
₹900.00
Reviews
There are no reviews yet.